1,241 results on '"Abu-Rustum, Nadeem"'
Search Results
2. Molecular image–guided surgery in gynaecological cancer: where do we stand?
3. ASO Visual Abstract: Oncologic and Perioperative Outcomes of Robot-Assisted Versus Conventional Laparoscopy for the Treatment of Clinically Uterine-Confined High-Grade Adenocarcinoma
4. Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium
5. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
6. Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
7. ChatGPT compared to national guidelines for management of ovarian cancer: Did ChatGPT get it right? – A Memorial Sloan Kettering Cancer Center Team Ovary study
8. Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements
9. Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake
10. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group
11. Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
12. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis
13. Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State
14. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus
15. Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
16. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
17. Isolated vaginal recurrence in women with stage I endometrial cancer
18. TERT promoter mutations and gene amplification in endometrial cancer
19. Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
20. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
21. HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
22. Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study
23. Incidence and Clinicopathologic Characteristics of Human Papillomavirus–independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases
24. Ovarian cancer mutational processes drive site-specific immune evasion
25. Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma
26. Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications
27. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
28. Germline drivers of gynecologic carcinosarcomas
29. Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype
30. Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study
31. Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study
32. Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
33. Genomic landscape of endometrial carcinomas of no specific molecular profile
34. The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma
35. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline
36. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment
37. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes
38. Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system
39. Enhanced PAtient Clinical Streamlining (EPACS): Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits
40. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment
41. Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases
42. Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study
43. ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype.
44. 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.
45. Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study.
46. Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer.
47. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition
48. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification
49. International expert consensus on the surgical anatomic classification of radical hysterectomies
50. Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.